SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Cognitive Neurology Referral — Sugar Ray Robinson
| Patient | Sugar Ray Robinson |
|---|
| Date of birth | 1963-05-03 |
|---|
| Identifiers | MRN HR-BX003-SYN; SSN (made up) 000-03-9318 |
|---|
| Document date | 2026-07-07 |
|---|
| Author | Langston Pryce-Okonjo, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Two years of progressive memory loss with getting lost while driving in a retired professional boxer of 63 with type 2 diabetes and hypertension; MoCA 18. Please stage the impairment, weigh Alzheimer's disease against traumatic encephalopathy syndrome and vascular disease, advise on biomarker testing and on eligibility for anti-amyloid therapy, and help us plan safety and support. [S]
Urgency: Routine; at the memory clinic two weeks from now, on the same day as his two-week primary care visit, with brain MRI and audiometry that morning. [S]
Questions for the consultant:
- What is the stage of his impairment, and is the pattern most consistent with Alzheimer's disease?
- How should we think about traumatic encephalopathy syndrome and chronic traumatic encephalopathy after his boxing career, and about vascular disease?
- Which biomarker test do you advise, and should APOE genotyping be done?
- Is he a candidate for lecanemab or donanemab under the appropriate use recommendations?
- What do you advise for symptomatic treatment, driving, firearm safety, hearing and support for his care partner?
History of Present Illness
Retired world champion boxer: about 200 professional bouts over 25 years after an amateur career. Memory loss for about two years, worse in the past six months: repeated questions, missed bills and appointments, and lost twice in familiar streets while driving. Independent in personal care; needs help with finances and medicines (Functional Activities Questionnaire 11). MoCA 18 with losses in delayed recall, orientation and executive tasks; PHQ-9 4. About ten years of schooling. Diabetes on metformin and glipizide (hemoglobin A1c 6.4%); hypertension on lisinopril; atorvastatin. Diphenhydramine 25 mg nightly stopped today. Blood count, metabolic panel (creatinine 1.0 mg/dL, eGFR 85), B12 352 pg/mL and TSH 1.9 normal; urine albumin-to-creatinine ratio 14 mg/g. STOP-Bang 2. No anticoagulant. He has agreed not to drive until the work-up is done; a handgun at home is unloaded and locked with the key held by his care partner, who comes to visits [S]
- He wants to know why he is forgetting and what can be done. [S]
- He wants to keep his independence and keep working with the young fighters at the foundation. [S]
- His care partner is worried about his driving and about managing alone. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- He was born Walker Smith Jr. on May 3, 1921. The Michigan Sports Hall of Fame gives his birthplace as Ailey, Georgia, with the family later moving to Detroit; the 1989 UPI obituary says he was born in Detroit. [D]
- As a boy he moved with his family to Harlem in New York, and he won the Golden Gloves featherweight title in 1939. [D]
- He held the world welterweight championship, won in 1946, and the world middleweight title five times, first in 1951. [D]
- He boxed professionally from 1940 to 1965, about 200 bouts in all: the 1989 UPI obituary counts 201 fights, 109 won by knockout and 65 by decision; the 1987 UPI report gives a record of 174-19-6 and the Michigan Sports Hall of Fame 173-19-6. [D]
- After boxing he settled in Los Angeles, living modestly in the top story of a duplex on West Adams Boulevard, and in 1969 founded the Sugar Ray Robinson Youth Foundation for inner-city children in the Los Angeles area. [D]
- The project roster describes his dementia as probable boxing-related dementia pugilistica; no source read records that diagnosis, chronic traumatic encephalopathy, or an autopsy finding. [R]
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Metformin 1,000 mg oral tablet, one tablet twice daily with meals | One tablet twice daily with meals | Oral route | 2024-03-01 | active | S |
| Glipizide 5 mg oral tablet, one tablet before breakfast | One tablet before breakfast | Oral route | 2025-01-15 to 2026-08-18 | completed | S |
| Lisinopril 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2023-06-01 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2024-03-01 | active | S |
| Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counter | One capsule at bedtime | Oral route | 2025-10-01 to 2026-07-07 | stopped | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be found | active | confirmed |
R41.3 | S — Synthetic presenting problem anchored to his documented Alzheimer's disease; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age. |
| Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylurea | active | confirmed |
E11.9 | S — Synthetic modern diabetes anchored to his documented diabetes. |
| Hypertension, controlled on lisinopril | active | confirmed |
I10 | S — Synthetic modern hypertension anchored to the single press report. |
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| 1940 to 1965 | About 200 professional bouts over 25 years of boxing, after an amateur career: long exposure to repetitive head impacts; no source read records a knockout count with loss of consciousness or a brain injury diagnosis | D (CLM-0002, CLM-0004) |
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Retired world champion boxer; lives in Los Angeles in the upper floor of a duplex with his care partner, who comes to visits with him; still visits the gym of the youth foundation he started [S]
- Finished school to about the tenth grade; spent his working life in boxing and in business around it [S]
- Drives a car; got lost twice in familiar streets this year; no crashes [S]
- A handgun in the home, kept unloaded in a locked box [S]
- Does not smoke; a glass of wine on special occasions; no other drugs [S]
- Exercises daily: long walks and skipping rope; eats two large meals a day [S]
- Strengths and supports: discipline and daily exercise, pride in his career, a warm and sociable manner, his care partner, friends from boxing, and the young people at the foundation [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-07-07 | Body height | 180 | cm | S |
| 2026-07-07 | Body weight | 77 | kg | S |
| 2026-07-07 | Body mass index (BMI) [Ratio] | 23.8 | kg/m2 | S |
| 2026-07-07 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-07-07 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-07-07 | Heart rate | 72 | /min | S |
| 2026-07-07 | Respiratory rate | 14 | /min | S |
| 2026-07-07 | Body temperature | 36.7 | Cel | S |
| 2026-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-07-07 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-07-07 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 2026-07-07 | Platelets [#/volume] in Blood by Automated count | 231 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-07-07 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-07-07 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-07-07 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-07-07 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 85 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-07 | Glucose [Mass/volume] in Serum or Plasma | 126 | mg/dL | 70-140 mg/dL | Normal | S |
| 2026-07-07 | Hemoglobin A1c/Hemoglobin.total in Blood | 6.4 | % | <=5.6% | High | S |
| 2026-07-07 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 352 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-07-07 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-07-07 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g | <=29 mg/g | Normal | S |
| 2026-07-07 | Total score [MoCA] | 18 | {score} | | | S |
| 2026-07-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | | | S |
Assessment
- Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be found: active, confirmed [S]
- Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylurea: active, confirmed [S]
- Hypertension, controlled on lisinopril: active, confirmed [S]
Plan of Treatment
- Dementia work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a review of medicines for anticholinergic and sedating drugs, a sleep apnea screen, and brain MRI. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, diabetes type 2 and hypertension monographs (2026) [S]
- Stop diphenhydramine, a strongly anticholinergic sleep aid; sleep habits and morning light instead. Guideline: American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023) [S]
- Driving: no driving until the evaluation is complete, with his care partner driving; firearm: unloaded and locked, with the key held by his care partner, until a decision with him. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Practice Parameter update: Evaluation and management of driving risk in dementia (2010) [S]
- Blood pressure under 130/80 mmHg on lisinopril, with potassium and creatinine checks. Guideline: CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, diabetes type 2 and hypertension monographs (2026); 13. Older Adults: Standards of Care in Diabetes-2026 (2026) [S]
- Advance care planning while he can take part fully: a health care agent and his values, at the preventive visit. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024) [S]
- Exercise, social activity and diabetes and blood pressure control as the brain-health measures with the most support. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); 13. Older Adults: Standards of Care in Diabetes-2026 (2026) [S]
- Referral to cognitive neurology, Mireille Haddad-Kowalski, MD, ordered 2026-07-07 [S]